Clinical

Electroencephalography and eye-tracking measures as scalable biomarker-based predictors of ASD in high-risk infants

As a supplement to a National Institutes of Health (NIH)-funded IBIS Network study of magnetic resonance imaging predictors of ASD in high familial risk (HR) infants, Shafali Spurling Jeste proposes using electroencephalography and eye-tracking biomarkers to test more scalable predictors of ASD. This study will involve participants from the same cohort as the larger NIH study, which includes recruitment from five sites across the United States. Findings from this project may lead to more accurate early presymptomatic identification and more timely intervention for HR infants.

Evaluating two newly developed treatment outcome measures (BOSCC and ELSA) in the context of an ASD behavioral intervention trial

Impairments in social communication are among the core symptoms of ASD, but at present, there are no validated tools that can be used to evaluate social communication outcomes in clinical trials. Researchers from three sites across the United States will validate two newly developed treatment outcome measures — the Brief Observation of Social Communication Change (BOSCC) and Elicitation of Language Samples for Analysis (ELSA) over the course of an ASD behavioral intervention trial (JASPER).

  • Previous Page
  • Viewing
  • Next Page
Subscribe to our newsletter and receive SFARI funding announcements and news

privacy consent banner

Privacy preference

We use cookies to provide you with the best online experience. By clicking "Accept All," you help us understand how our site is used and enhance its performance. You can change your choice at any time here. To learn more, please visit our Privacy Policy.